About
Steven K. Burke, M.D. joined Akebia Therapeutics in August 2019 and serves as Senior Vice President, Chief Research & Development Officer and Medical Officer. From August 2006 to July 2019 he served as Senior Vice President and Chief Medical Officer of Proteon Therapeutics, Inc., a company developing therapeutics for patients with kidney and vascular diseases. From 2001 to 2006 he was Senior Vice President of Medical and Regulatory Affairs at Genzyme, and from 1994 to 2000 he held roles at GelTex Pharmaceuticals, Inc. including Vice President of Clinical Research and Medical Director. He received an A.B. from Harvard College and an M.D. from Cornell University Medical College.
Roles
Akebia Therapeutics, Inc.
Senior Vice President, Chief Research & Development Officer and Medical Officer · Current role
2019–present
Proteon Therapeutics, Inc.
Senior Vice President and Chief Medical Officer · Company developing therapeutics for kidney and vascular diseases.
2006-2019
Genzyme
Senior Vice President of Medical and Regulatory Affairs
2001-2006
GelTex Pharmaceuticals, Inc.
Vice President of Clinical Research and Medical Director
1994-2000
Fixed Compensation
FY 2025
All other compensation
$17,500
Total compensation
$1,859,815
Performance Compensation
Data from FY 2025
Cash incentive
Annual cash incentive
$242,286
Stock awards
Also at Akebia Therapeutics, Inc.